Advertisement
Canada markets close in 4 hours 39 minutes
  • S&P/TSX

    21,821.04
    +112.60 (+0.52%)
     
  • S&P 500

    4,994.87
    -16.25 (-0.32%)
     
  • DOW

    37,937.05
    +161.67 (+0.43%)
     
  • CAD/USD

    0.7281
    +0.0017 (+0.24%)
     
  • CRUDE OIL

    83.34
    +0.61 (+0.74%)
     
  • Bitcoin CAD

    88,531.66
    +919.84 (+1.05%)
     
  • CMC Crypto 200

    1,334.09
    +21.46 (+1.66%)
     
  • GOLD FUTURES

    2,408.70
    +10.70 (+0.45%)
     
  • RUSSELL 2000

    1,945.98
    +3.02 (+0.16%)
     
  • 10-Yr Bond

    4.6190
    -0.0280 (-0.60%)
     
  • NASDAQ

    15,439.08
    -162.42 (-1.04%)
     
  • VOLATILITY

    18.51
    +0.51 (+2.83%)
     
  • FTSE

    7,892.56
    +15.51 (+0.20%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Top Ranked Momentum Stocks to Buy for March 9th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 9th:

BioCryst Pharmaceuticals, Inc. (BCRX): This biotechnology company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.6% over the last 60 days.

BioCryst Pharmaceuticals, Inc. Price and Consensus

BioCryst Pharmaceuticals, Inc. Price and Consensus
BioCryst Pharmaceuticals, Inc. Price and Consensus

BioCryst Pharmaceuticals, Inc. price-consensus-chart | BioCryst Pharmaceuticals, Inc. Quote

BioCryst Pharmaceuticals’ shares gained 38.4% over the last one month above the S&P 500’s decrease of 11.3%. The company possesses a Momentum Score of A.

BioCryst Pharmaceuticals, Inc. Price

BioCryst Pharmaceuticals, Inc. Price
BioCryst Pharmaceuticals, Inc. Price

BioCryst Pharmaceuticals, Inc. price | BioCryst Pharmaceuticals, Inc. Quote

ADVERTISEMENT

Kinross Gold Corporation (KGC): This explorer, acquirer and developer of gold properties has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19% over the last 60 days.

Kinross Gold Corporation Price and Consensus

Kinross Gold Corporation Price and Consensus
Kinross Gold Corporation Price and Consensus

Kinross Gold Corporation price-consensus-chart | Kinross Gold Corporation Quote

Kinross Gold’s shares gained 11.4% over the last one month. The company possesses a Momentum Score of A.

Kinross Gold Corporation Price

Kinross Gold Corporation Price
Kinross Gold Corporation Price

Kinross Gold Corporation price | Kinross Gold Corporation Quote

Livongo Health, Inc. (LVGO): This provider of an integrated suite of solutions for the healthcare industry has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 31% over the last 60 days.

Livongo Health, Inc. Price and Consensus

Livongo Health, Inc. Price and Consensus
Livongo Health, Inc. Price and Consensus

Livongo Health, Inc. price-consensus-chart | Livongo Health, Inc. Quote

Livongo Health’s shares gained 12.6% over the last one month. The company possesses a Momentum Score of A.

Livongo Health, Inc. Price

Livongo Health, Inc. Price
Livongo Health, Inc. Price

Livongo Health, Inc. price | Livongo Health, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

More Stock News: This Is Bigger than the iPhone!                  

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>

 


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Livongo Health, Inc. (LVGO) : Free Stock Analysis Report
 
Kinross Gold Corporation (KGC) : Free Stock Analysis Report
 
BioCryst Pharmaceuticals, Inc. (BCRX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research